Stock Code: Guangzhou Improve Medical Instruments Co.Ltd(300030) stock abbreviation: Guangzhou Improve Medical Instruments Co.Ltd(300030) Announcement No.: 2022014 bond Code: 112522 bond abbreviation: 17 Yangpu S1
Guangzhou Improve Medical Instruments Co.Ltd(300030) Technology Co., Ltd
Announcement on 2021 profit distribution plan
The company and all members of its board of directors guarantee that the contents of the announcement are true, accurate and complete without false records, misleading statements or major omissions.
On April 21, 2022, Guangzhou Improve Medical Instruments Co.Ltd(300030) Technology Co., Ltd. (hereinafter referred to as “the company”) held the 17th meeting of the 5th board of directors and the 13th meeting of the 5th board of supervisors, which deliberated and adopted the proposal on the profit distribution plan in 2021. The independent directors of the company expressed their independent opinions on the profit distribution plan, which needs to be submitted to the 2021 annual general meeting of the company for deliberation. The basic information of the proposal is hereby announced as follows:
1、 Specific contents of profit distribution plan
Audited by Lixin Certified Public Accountants (special general partnership), the company’s net profit attributable to the owner of the parent company in 2021 was 1856852932 yuan. As of December 31, 2021, the total profit available for distribution to all shareholders of the parent company was 24112659882 yuan, and the balance of capital reserve was 39905423243 yuan. Considering the current overall operation and development stage of the company, in accordance with the guidance of the CSRC on encouraging listed companies to pay cash dividends and giving investors stable and reasonable returns, and taking into account the immediate and long-term interests of shareholders on the premise of conforming to the principle of profit distribution and ensuring the normal operation and long-term development of the company, The company’s profit distribution plan for 2021 is as follows: Based on the total share capital of 309187315 shares on December 31, 2021, a cash dividend of 0.4 yuan (including tax) will be distributed for every 10 shares, with a total cash distribution of 123674926 yuan. The remaining undistributed profits will be carried forward for annual distribution in the future.
2、 Legality and compliance of profit distribution plan
The profit distribution plan complies with the provisions and requirements of the company law, the securities law, the accounting standards for business enterprises, the notice on matters related to the further implementation of cash dividends of listed companies, the guidelines for the supervision of listed companies No. 3 – cash dividends of listed companies (revised in 2022) and the company’s charter, as well as the profit distribution policy, profit distribution plan, long-term return plan of shareholders and relevant commitments made by the company, It is conducive to all shareholders to share the operating results of the company. This profit distribution plan meets the needs of the company’s future operation and development, and has legitimacy, compliance and rationality.
3、 Opinions of independent directors
Independent directors believe that the company’s profit distribution plan for 2021 complies with laws, regulations, the articles of association and other relevant provisions, conforms to the company’s overall development strategy and actual operation, is conducive to the sustainable and stable development of the company, and does not harm the interests of the company and all shareholders, especially small and medium-sized shareholders. All independent directors agree with the company’s profit distribution plan for 2021.
4、 Opinions of the board of supervisors
After review, the board of supervisors believes that the company’s 2021 profit distribution plan complies with the provisions of the articles of association and relevant accounting standards and policies. The formulation procedure of the company’s profit distribution plan is legal and compliant, which is conducive to the company’s sustainable, stable and healthy development and return to shareholders.
5、 Other instructions
This profit distribution plan needs to be submitted to the 2021 annual general meeting of shareholders of the company for deliberation, and can be implemented only after it is deliberated and approved. Please pay attention to the investment risks.
6、 Documents for future reference
1. Resolutions of the 17th meeting of the 5th board of directors;
2. Resolutions of the 13th meeting of the 5th board of supervisors;
3. Independent opinions of independent directors on matters related to the 17th meeting of the Fifth Board of directors.
It is hereby announced.
Guangzhou Improve Medical Instruments Co.Ltd(300030) technology Co., Ltd. board of directors April 22, 2022
